Erin Wright
Stock Analyst at Morgan Stanley
(4.49)
# 295
Out of 5,148 analysts
253
Total ratings
64.77%
Success rate
14.48%
Average return
Main Sectors:
Stocks Rated by Erin Wright
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HSIC Henry Schein | Maintains: Underweight | $58 → $61 | $81.37 | -25.03% | 6 | Feb 25, 2026 | |
| ELAN Elanco Animal Health | Maintains: Equal-Weight | $22 → $24 | $26.09 | -8.01% | 13 | Feb 25, 2026 | |
| PSX Phillips 66 | Maintains: Equal-Weight | $140 → $147 | $160.18 | -8.23% | 3 | Feb 5, 2026 | |
| ALGN Align Technology | Maintains: Equal-Weight | $154 → $169 | $189.02 | -10.59% | 26 | Feb 5, 2026 | |
| HUM Humana | Downgrades: Underweight | $262 → $174 | $187.28 | -7.09% | 6 | Feb 2, 2026 | |
| COR Cencora | Upgrades: Overweight | $361 → $400 | $372.65 | +7.34% | 2 | Jan 29, 2026 | |
| CAH Cardinal Health | Maintains: Overweight | $224 → $245 | $229.88 | +6.58% | 13 | Jan 29, 2026 | |
| OPCH Option Care Health | Maintains: Overweight | $35 → $38 | $31.60 | +20.25% | 2 | Jan 13, 2026 | |
| ELV Elevance Health | Maintains: Equal-Weight | $359 → $352 | $294.07 | +19.70% | 5 | Dec 18, 2025 | |
| CVS CVS Health | Maintains: Overweight | $89 → $93 | $81.66 | +13.89% | 7 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $211 → $175 | $128.96 | +35.70% | 8 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $857 → $916 | $990.95 | -7.56% | 10 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $765 → $805 | $636.70 | +26.43% | 19 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $163 → $204 | $152.42 | +33.84% | 3 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $32 | $41.58 | -23.04% | 4 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $29.44 | -42.26% | 9 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $26 | $54.54 | -52.33% | 23 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $379 → $390 | $290.85 | +34.09% | 5 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $3.5 → $3.2 | $2.73 | +17.22% | 12 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $23 | $14.31 | +60.73% | 12 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $145 → $172 | $210.25 | -18.19% | 5 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $587 | $294.93 | +99.03% | 3 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Overweight | $300 | $286.47 | +4.72% | 4 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $39 → $42 | $8.81 | +376.73% | 5 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $282 → $288 | $206.00 | +39.81% | 6 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $342 → $352 | $178.61 | +97.08% | 4 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $42 → $44 | $3.61 | +1,118.84% | 2 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $178 → $181 | $457.47 | -60.43% | 8 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $76.30 | -77.72% | 6 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $121 | $27.07 | +346.99% | 7 | Jan 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $556 → $580 | $508.58 | +14.04% | 4 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $35 | $7.05 | +396.45% | 1 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $181 → $205 | $108.27 | +89.34% | 2 | Jul 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $14.20 | -22.54% | 6 | May 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $175 → $157 | $174.27 | -9.91% | 1 | Apr 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $300 → $308 | $676.70 | -54.49% | 1 | Oct 25, 2017 |
Henry Schein
Feb 25, 2026
Maintains: Underweight
Price Target: $58 → $61
Current: $81.37
Upside: -25.03%
Elanco Animal Health
Feb 25, 2026
Maintains: Equal-Weight
Price Target: $22 → $24
Current: $26.09
Upside: -8.01%
Phillips 66
Feb 5, 2026
Maintains: Equal-Weight
Price Target: $140 → $147
Current: $160.18
Upside: -8.23%
Align Technology
Feb 5, 2026
Maintains: Equal-Weight
Price Target: $154 → $169
Current: $189.02
Upside: -10.59%
Humana
Feb 2, 2026
Downgrades: Underweight
Price Target: $262 → $174
Current: $187.28
Upside: -7.09%
Cencora
Jan 29, 2026
Upgrades: Overweight
Price Target: $361 → $400
Current: $372.65
Upside: +7.34%
Cardinal Health
Jan 29, 2026
Maintains: Overweight
Price Target: $224 → $245
Current: $229.88
Upside: +6.58%
Option Care Health
Jan 13, 2026
Maintains: Overweight
Price Target: $35 → $38
Current: $31.60
Upside: +20.25%
Elevance Health
Dec 18, 2025
Maintains: Equal-Weight
Price Target: $359 → $352
Current: $294.07
Upside: +19.70%
CVS Health
Dec 10, 2025
Maintains: Overweight
Price Target: $89 → $93
Current: $81.66
Upside: +13.89%
Nov 10, 2025
Maintains: Overweight
Price Target: $211 → $175
Current: $128.96
Upside: +35.70%
Nov 6, 2025
Maintains: Overweight
Price Target: $857 → $916
Current: $990.95
Upside: -7.56%
Nov 4, 2025
Maintains: Overweight
Price Target: $765 → $805
Current: $636.70
Upside: +26.43%
Oct 14, 2025
Maintains: Equal-Weight
Price Target: $163 → $204
Current: $152.42
Upside: +33.84%
Oct 14, 2025
Maintains: Overweight
Price Target: $25 → $32
Current: $41.58
Upside: -23.04%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $29.44
Upside: -42.26%
Jun 25, 2025
Maintains: Equal-Weight
Price Target: $21 → $26
Current: $54.54
Upside: -52.33%
May 5, 2025
Maintains: Overweight
Price Target: $379 → $390
Current: $290.85
Upside: +34.09%
Apr 17, 2025
Maintains: Underweight
Price Target: $3.5 → $3.2
Current: $2.73
Upside: +17.22%
Dec 17, 2024
Maintains: Overweight
Price Target: $30 → $23
Current: $14.31
Upside: +60.73%
Dec 17, 2024
Upgrades: Overweight
Price Target: $145 → $172
Current: $210.25
Upside: -18.19%
Jul 14, 2023
Reiterates: Overweight
Price Target: $587
Current: $294.93
Upside: +99.03%
Aug 22, 2022
Assumes: Overweight
Price Target: $300
Current: $286.47
Upside: +4.72%
Jul 30, 2021
Maintains: Outperform
Price Target: $39 → $42
Current: $8.81
Upside: +376.73%
Jun 18, 2021
Maintains: Outperform
Price Target: $282 → $288
Current: $206.00
Upside: +39.81%
May 28, 2021
Maintains: Neutral
Price Target: $342 → $352
Current: $178.61
Upside: +97.08%
May 11, 2021
Maintains: Outperform
Price Target: $42 → $44
Current: $3.61
Upside: +1,118.84%
Mar 17, 2021
Maintains: Outperform
Price Target: $178 → $181
Current: $457.47
Upside: -60.43%
Feb 26, 2021
Maintains: Neutral
Price Target: $14 → $17
Current: $76.30
Upside: -77.72%
Jan 13, 2021
Maintains: Outperform
Price Target: $104 → $121
Current: $27.07
Upside: +346.99%
Jan 12, 2021
Maintains: Outperform
Price Target: $556 → $580
Current: $508.58
Upside: +14.04%
Jan 5, 2021
Initiates: Neutral
Price Target: $35
Current: $7.05
Upside: +396.45%
Jul 23, 2020
Maintains: Outperform
Price Target: $181 → $205
Current: $108.27
Upside: +89.34%
May 5, 2020
Maintains: Neutral
Price Target: $12 → $11
Current: $14.20
Upside: -22.54%
Apr 2, 2020
Maintains: Outperform
Price Target: $175 → $157
Current: $174.27
Upside: -9.91%
Oct 25, 2017
Maintains: Neutral
Price Target: $300 → $308
Current: $676.70
Upside: -54.49%